In marked contrast, only 30% and 20% mice had obvious liver and kidney metastasis respectively in RBP2 shRNA group (Figure 1h and Supplementary Figure 1f), suggesting that RBP2 inhibition decreased tumor metastasis in vivo, which was in agreement with the previous results in vitro. This evidence concerns the gene RBP2 and neoplasm.